Amniotic fluid exhibits an innate inhibitory activity against HIV type 1 replication in vitro

Azadeh Farzin, Pamela Boyer, Bonnie Ank, Karin Nielsen-Saines, Yvonne Bryson

Research output: Contribution to journalArticle

Abstract

Indirect evidence suggests that amniotic fluid (AF) may play a role in the pathogenesis of in utero HIV-1 transmission. The purpose of this study was to evaluate the potential innate inhibitory role of AF on HIV replication, which may contribute to protection of the fetus against intrauterine transmission. AF was collected from term HIV-1-negative women undergoing scheduled cesarean section. The inhibitory effect of AF against HIV-1BA-L replication was tested in vitro with or without the addition of protease inhibitor cocktail (PIC) in PHA-stimulated PBMC cultures. Quantitative measurement of human neutrophil peptides 1-3 (HNP1-3) was performed on all AF samples, using an ELISA assay. AF exhibited a dose-dependent inhibitory activity against HIV-1 BA-L replication, with all samples (n=12) reaching significant inhibitory effect using 50% AF. In vitro, this activity decreased over time, but was able to be sustained with the addition of PIC. The HNP1-3 concentration in AF samples (n=12) ranged from undetectable (250,000 pg/ml with a median of 5,146 pg/ml. AF exhibited a significant and dose-dependent innate inhibitory activity against HIV-1 replication, which was present in all AF samples tested. This effect was prolonged in the presence of PIC, suggesting that the inhibitory factor was in the cell-free protein fraction. The HNP1-3 concentration in AF was in the subinhibitory range for HIV with no correlation between its concentration and the HIV-1 inhibitory activity. These data show the presence of a significant innate inhibitory activity against HIV in AF.

Original languageEnglish (US)
Pages (from-to)77-83
Number of pages7
JournalAIDS Research and Human Retroviruses
Volume29
Issue number1
DOIs
StatePublished - Jan 1 2013
Externally publishedYes

Fingerprint

Amniotic Fluid
HIV-1
Protease Inhibitors
HIV
In Vitro Techniques
Cesarean Section
Fetus
Enzyme-Linked Immunosorbent Assay

ASJC Scopus subject areas

  • Immunology
  • Virology
  • Infectious Diseases

Cite this

Amniotic fluid exhibits an innate inhibitory activity against HIV type 1 replication in vitro. / Farzin, Azadeh; Boyer, Pamela; Ank, Bonnie; Nielsen-Saines, Karin; Bryson, Yvonne.

In: AIDS Research and Human Retroviruses, Vol. 29, No. 1, 01.01.2013, p. 77-83.

Research output: Contribution to journalArticle

Farzin, Azadeh ; Boyer, Pamela ; Ank, Bonnie ; Nielsen-Saines, Karin ; Bryson, Yvonne. / Amniotic fluid exhibits an innate inhibitory activity against HIV type 1 replication in vitro. In: AIDS Research and Human Retroviruses. 2013 ; Vol. 29, No. 1. pp. 77-83.
@article{a2bb3ceaa4884bc1885f8ff9bd71e955,
title = "Amniotic fluid exhibits an innate inhibitory activity against HIV type 1 replication in vitro",
abstract = "Indirect evidence suggests that amniotic fluid (AF) may play a role in the pathogenesis of in utero HIV-1 transmission. The purpose of this study was to evaluate the potential innate inhibitory role of AF on HIV replication, which may contribute to protection of the fetus against intrauterine transmission. AF was collected from term HIV-1-negative women undergoing scheduled cesarean section. The inhibitory effect of AF against HIV-1BA-L replication was tested in vitro with or without the addition of protease inhibitor cocktail (PIC) in PHA-stimulated PBMC cultures. Quantitative measurement of human neutrophil peptides 1-3 (HNP1-3) was performed on all AF samples, using an ELISA assay. AF exhibited a dose-dependent inhibitory activity against HIV-1 BA-L replication, with all samples (n=12) reaching significant inhibitory effect using 50{\%} AF. In vitro, this activity decreased over time, but was able to be sustained with the addition of PIC. The HNP1-3 concentration in AF samples (n=12) ranged from undetectable (250,000 pg/ml with a median of 5,146 pg/ml. AF exhibited a significant and dose-dependent innate inhibitory activity against HIV-1 replication, which was present in all AF samples tested. This effect was prolonged in the presence of PIC, suggesting that the inhibitory factor was in the cell-free protein fraction. The HNP1-3 concentration in AF was in the subinhibitory range for HIV with no correlation between its concentration and the HIV-1 inhibitory activity. These data show the presence of a significant innate inhibitory activity against HIV in AF.",
author = "Azadeh Farzin and Pamela Boyer and Bonnie Ank and Karin Nielsen-Saines and Yvonne Bryson",
year = "2013",
month = "1",
day = "1",
doi = "10.1089/aid.2011.0355",
language = "English (US)",
volume = "29",
pages = "77--83",
journal = "AIDS Research and Human Retroviruses",
issn = "0889-2229",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - Amniotic fluid exhibits an innate inhibitory activity against HIV type 1 replication in vitro

AU - Farzin, Azadeh

AU - Boyer, Pamela

AU - Ank, Bonnie

AU - Nielsen-Saines, Karin

AU - Bryson, Yvonne

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Indirect evidence suggests that amniotic fluid (AF) may play a role in the pathogenesis of in utero HIV-1 transmission. The purpose of this study was to evaluate the potential innate inhibitory role of AF on HIV replication, which may contribute to protection of the fetus against intrauterine transmission. AF was collected from term HIV-1-negative women undergoing scheduled cesarean section. The inhibitory effect of AF against HIV-1BA-L replication was tested in vitro with or without the addition of protease inhibitor cocktail (PIC) in PHA-stimulated PBMC cultures. Quantitative measurement of human neutrophil peptides 1-3 (HNP1-3) was performed on all AF samples, using an ELISA assay. AF exhibited a dose-dependent inhibitory activity against HIV-1 BA-L replication, with all samples (n=12) reaching significant inhibitory effect using 50% AF. In vitro, this activity decreased over time, but was able to be sustained with the addition of PIC. The HNP1-3 concentration in AF samples (n=12) ranged from undetectable (250,000 pg/ml with a median of 5,146 pg/ml. AF exhibited a significant and dose-dependent innate inhibitory activity against HIV-1 replication, which was present in all AF samples tested. This effect was prolonged in the presence of PIC, suggesting that the inhibitory factor was in the cell-free protein fraction. The HNP1-3 concentration in AF was in the subinhibitory range for HIV with no correlation between its concentration and the HIV-1 inhibitory activity. These data show the presence of a significant innate inhibitory activity against HIV in AF.

AB - Indirect evidence suggests that amniotic fluid (AF) may play a role in the pathogenesis of in utero HIV-1 transmission. The purpose of this study was to evaluate the potential innate inhibitory role of AF on HIV replication, which may contribute to protection of the fetus against intrauterine transmission. AF was collected from term HIV-1-negative women undergoing scheduled cesarean section. The inhibitory effect of AF against HIV-1BA-L replication was tested in vitro with or without the addition of protease inhibitor cocktail (PIC) in PHA-stimulated PBMC cultures. Quantitative measurement of human neutrophil peptides 1-3 (HNP1-3) was performed on all AF samples, using an ELISA assay. AF exhibited a dose-dependent inhibitory activity against HIV-1 BA-L replication, with all samples (n=12) reaching significant inhibitory effect using 50% AF. In vitro, this activity decreased over time, but was able to be sustained with the addition of PIC. The HNP1-3 concentration in AF samples (n=12) ranged from undetectable (250,000 pg/ml with a median of 5,146 pg/ml. AF exhibited a significant and dose-dependent innate inhibitory activity against HIV-1 replication, which was present in all AF samples tested. This effect was prolonged in the presence of PIC, suggesting that the inhibitory factor was in the cell-free protein fraction. The HNP1-3 concentration in AF was in the subinhibitory range for HIV with no correlation between its concentration and the HIV-1 inhibitory activity. These data show the presence of a significant innate inhibitory activity against HIV in AF.

UR - http://www.scopus.com/inward/record.url?scp=84871859727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871859727&partnerID=8YFLogxK

U2 - 10.1089/aid.2011.0355

DO - 10.1089/aid.2011.0355

M3 - Article

C2 - 22998428

AN - SCOPUS:84871859727

VL - 29

SP - 77

EP - 83

JO - AIDS Research and Human Retroviruses

JF - AIDS Research and Human Retroviruses

SN - 0889-2229

IS - 1

ER -